Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
4.120
-0.150 (-3.51%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sera Prognostics Revenue
Sera Prognostics had revenue of $29.00K in the quarter ending September 30, 2024, a decrease of -30.95%. This brings the company's revenue in the last twelve months to $94.00K, down -71.52% year-over-year. In the year 2023, Sera Prognostics had annual revenue of $306.00K with 14.18% growth.
Revenue (ttm)
$94.00K
Revenue Growth
-71.52%
P/S Ratio
1,480.24
Revenue / Employee
$1,649
Employees
57
Market Cap
139.14M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 306.00K | 38.00K | 14.18% |
Dec 31, 2022 | 268.00K | 186.00K | 226.83% |
Dec 31, 2021 | 82.00K | 57.00K | 228.00% |
Dec 31, 2020 | 25.00K | -11.00K | -30.56% |
Dec 31, 2019 | 36.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SERA News
- 1 day ago - Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference - PRNewsWire
- 11 days ago - Sera Prognostics Announces Pricing of $50 Million Public Offering - PRNewsWire
- 11 days ago - Sera Prognostics Announces Proposed Public Offering - PRNewsWire
- 25 days ago - Sera Prognostics to Host Virtual R&D Day on January 31 - PRNewsWire
- 6 weeks ago - Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting - PRNewsWire
- 2 months ago - Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 3 months ago - Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PRNewsWire